TABLE 1.
Cytokine | CYPs | Effects on CYPs | mRNA or protein or activity | Condition | Studies |
---|---|---|---|---|---|
IL-6 | CYP1A1 | ↓ | mRNA and protein | Human HepG2 hepatoma cells | Fukuda and Sassa (1994) |
CYP1A2 | ↓ | mRNA | Hepatoma cells (HepG2, HepG2f and Hep3B) | Fukuda et al. (1992) | |
Turpentine-induced aseptic inflammation in IL-6-deficient mice | Siewert et al. (2000) | ||||
Human HepaRG hepatoma cell line | Rubin et al. (2015) | ||||
↓ | Activity | Human HepaRG hepatoma cell line | Rubin et al. (2015) | ||
↑ | Activity | Clinical study in patients with active rheumatoid arthritis | Zhuang et al. (2015) | ||
CYP2A5 | ↓ | mRNA | Turpentine-induced aseptic inflammation in IL-6-deficient mice | Siewert et al. (2000) | |
CYP2A12 | ↓ | Activity | IL-6 knockout mice after LPS administration | Warren et al. (2001) | |
CYP2B6 | ↓ | mRNA | Human primary hepatocytes | Aitken and Morgan (2007) | |
Human HepaRG hepatoma cell line | Rubin et al. (2015) | ||||
↓ | Activity | Human HepaRG hepatoma cell line | Rubin et al. (2015) | ||
CYP2C8 | ↓ | mRNA | Human primary hepatocytes | Aitken and Morgan (2007) | |
CYP2C9 | ↓ | mRNA | Human primary hepatocytes | Aitken and Morgan (2007) | |
Activity | Clinical study in patients with active rheumatoid arthritis | Zhuang et al. (2015) | |||
CYP2C19 | ↓ | mRNA | Human primary hepatocytes | Aitken and Morgan (2007) | |
Activity | Clinical study in patients with active rheumatoid arthritis | Zhuang et al. (2015) | |||
CYP2E1 | ↓ | mRNA | Human primary hepatocytes | Abdel-Razzak et al. (1993) | |
CYP3 subfamily | ↓ | Activity | Clinical study in patients with active rheumatoid arthritis | Zhuang et al. (2015) | |
CYP3A3 | ↓ | mRNA | Hepatoma cells (HepG2, HepG2f and Hep3B) | Fukuda et al. (1992) | |
CYP3A4 | ↓ | mRNA | Both HepG2 and Caco-2 cells | Enokiya et al. (2021) | |
Human primary hepatocytes | Aitken and Morgan (2007) | ||||
Activity | Clinical study in patients with rheumatoid arthritis | Lee et al. (2017) | |||
Clinical study in patients with rheumatoid arthritis | Schmitt et al. (2011) | ||||
Human HepaRG hepatoma cell line | Rubin et al. (2015) | ||||
CYP3A5 | ↓ | mRNA | Both HepG2 and Caco-2 cells | Enokiya et al. (2021) | |
CYP3A11 | ↓ | mRNA | Turpentine-induced aseptic inflammation in IL-6-deficient mice | Siewert et al. (2000) | |
TNF-α | CYP1A1 | ↓ | mRNA and protein | Rat liver epithelial WB-F344 cells | Umannová et al. (2008) |
CYP1A2 | ↓ | mRNA | Human primary hepatocytes | Dallas et al. (2012) | |
CYP1B1 | ↑ | mRNA and protein | Rat liver epithelial WB-F344 cells | Umannová et al. (2008) | |
CYP2A4/5 | ↑ | mRNA | C. rodentium mice model of infectious colitis | Nyagode et al. (2014) | |
CYP2C8 | ↓ | mRNA | Cynomolgus hepatocytes | Uno et al. (2020) | |
CYP2C76 | ↓ | mRNA | Cynomolgus hepatocytes | Uno et al. (2020) | |
CYP2D6 | ↓ | mRNA | Human primary hepatocytes | Dallas et al. (2012) | |
CYP2E1 | ↓ | mRNA | Human primary hepatocytes | Abdel-Razzak et al. (1993) | |
CYP3A11 | ↓ | mRNA | Mouse hepatocytes | Kinloch et al. (2011) | |
C. rodentium mice model of infectious colitis | Nyagode et al. (2014) | ||||
CYP3A25 | ↓ | mRNA | Mouse hepatocytes | Kinloch et al. (2011) | |
C. rodentium mice model of infectious colitis | Nyagode et al. (2014) | ||||
CYP3A4 | ↓ | mRNA | Human primary hepatocytes | Dallas et al. (2012) | |
IL-1 | CYP1A1 | ↓ | mRNA | Isolated rat hepatocytes | Barker et al. (1992) |
cultured rabbit hepatocytes | Calleja et al. (1997) | ||||
CYP1A2 | ↓ | mRNA | Isolated rat hepatocytes | Barker et al. (1992) | |
cultured rabbit hepatocytes | Calleja et al. (1997) | ||||
IL-1β | CYP1A1 | ↓ | mRNA | Cynomolgus hepatocytes | Uno et al. (2020) |
CYP1A2 | ↓ | mRNA | Human primary hepatocytes | Abdel-Razzak et al. (1993) | |
CYP2B6 | ↓ | mRNA | Human hepatocytes | Assenat et al. (2004) | |
CYP2C8 | ↓ | mRNA | Cynomolgus hepatocytes | Uno et al. (2020) | |
CYP2C9 | ↓ | mRNA | Human hepatocytes | Assenat et al. (2004) | |
CYP2C11 | ↓ | mRNA | IL-1β-induced fevered rat | Kihara et al. (1998) | |
CYP2C19 | ↓ | mRNA | Cynomolgus hepatocytes | Uno et al. (2020) | |
CYP2C76 | ↓ | mRNA | Cynomolgus hepatocytes | Uno et al. (2020) | |
CYP3A4 | ↓ | mRNA | Human hepatocytes | Assenat et al. (2004) | |
CYP3A5 | ↑ | mRNA | Cynomolgus hepatocytes | Uno et al. (2020) | |
CYP3A subfamily | ↓ | mRNA | IL-1β-induced fevered rat | Kihara et al. (1998) | |
IFN-γ | CYP1A2 | ↓ | Protein | Human primary hepatocytes | Donato et al. (1997) |
CYP2B9 | ↓ | mRNA | LPS-induced septic mice model | Nyagode et al. (2010) | |
CYP2D9 | ↓ | mRNA | C. rodentium-induced colitis mice model | Nyagode et al. (2010) | |
CYP2D22 | ↓ | mRNA | C. rodentium-induced colitis mice model; LPS-induced septic mice model | Nyagode et al. (2010) | |
CYP2E1 | ↓ | mRNA | LPS-induced septic mice model | Nyagode et al. (2010) | |
CYP3A1 | ↓ | mRNA | Rat primary hepatocytes | Tapner et al. (1996) | |
CYP3A2 | ↓ | mRNA | Rat primary hepatocytes | Tapner et al. (1996) | |
CYP3A4 | ↓ | Protein | Human primary hepatocytes | Donato et al. (1997) | |
CYP3A11 | ↓ | mRNA | C. rodentium-induced colitis mice model | Nyagode et al. (2010) | |
CYP3A25 | ↓ | mRNA | C. rodentium-induced colitis mice model | Nyagode et al. (2010) | |
CYP4F18 | ↓ | mRNA | C. rodentium-induced colitis mice model | Nyagode et al. (2010) |
Abbreviations: COVID-19, coronavirus disease 2019; CYP, cytochrome P450; IL, interleukin; TNF, tumor necrosis factor; IFN, interferon; LPS, lipopolysaccharide. ↑ (Increased), ↓ (Reduced).